Finance

Lists
Why is BNTC down 3.94%?
Dive Deeper
BNTC:NASDAQ
Benitec Biopharma Inc
$8.29
-3.94%
(-0.34) 1D
Oct 14, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BNTC...
Open
$8.52
High
$9.07
Low
$8.25
Mkt. cap
289.18M
Avg. vol.
173.80K
Volume
0.00
52-wk high
$16.76
52-wk low
$8.25
EPS
-$0.98
Beta
0.25
Shares outstanding
34.88M
No. of employees
24
Open
$8.52
High
$9.07
Low
$8.25
Mkt. cap
289.18M
Avg. vol.
173.80K
Volume
0.00
52-wk high
$16.76
52-wk low
$8.25
EPS
-$0.98
Beta
0.25
Shares outstanding
34.88M
No. of employees
24
News stories
From web sources and news partners
About Benitec Biopharma Inc
CEO-
Employees24
Founded-
Headquarters-
SectorBiotechnology
Websitebenitec.com
Analyst ratings
Based on 4 analysts giving stock ratings to BNTC in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for BNTC in the last 3 months.
Highest
Current $8.29
$32.00 (+286.01%)
Average
$24.67 (+197.59%)
Lowest
$17.00 (+105.07%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$32.00
+286%
10/06/2026
Yun Zhong
Wedbush
Buy
Maintained
$17.00
+105.1%
10/05/2026
Ritu Baral
TD Cowen
Buy
Maintained
-
-
09/15/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
$25.00
+201.6%
09/15/2026
Debjit Chattopadhyay
Guggenheim
Hold
Downgraded
-
-
06/10/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
$18.00
+117.1%
05/15/2026
Silvan Tuerkcan
Citizens JMP
Buy
Maintained
$22.00
+165.4%
11/04/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.37M
5.83M
6.30M
7.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.43M
7.54M
7.28M
6.54M
Operating expense
9.80M
13.38M
13.58M
14.43M
Total operating expenses
9.80M
13.38M
13.58M
14.43M
Operating income
-9.80M
-13.38M
-13.58M
-14.43M
Other non operating income
-84.00K
19.00K
-17.00K
39.00K
EBT including unusual items
-8.96M
-11.84M
-11.94M
-12.81M
EBT excluding unusual items
-8.96M
-11.84M
-11.94M
-12.81M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.96M
-11.84M
-11.94M
-12.81M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.01M
1.39M
1.59M
1.57M
Interest expense
-
-
-
-
Net interest expenses
1.01M
1.39M
1.59M
1.57M
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.79M
-13.36M
-13.57M
-14.41M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps